Outcomes of Anti-BCMA CAR T Cell Therapy for Relapsed/refractory Multiple Myeloma: A Meta-Analysis

被引：0
|
作者：
Gagelmann, Nico [1 ]
Ayuk, Francis [1 ]
Atanackovic, Djordje [2 ]
Kroeger, Nicolaus [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Univ Utah, Salt Lake City, UT USA
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O122
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF ANTI-BCMA CAR T-CELL THERAPY IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA
    Barnes, J., I
    Frosch, Z. A.
    Garfall, A. L.
    Vogl, D.
    Lin, J.
    VALUE IN HEALTH, 2022, 25 (07) : S343 - S343
  • [42] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    D'Agostino, Mattia
    Raje, Noopur
    LEUKEMIA, 2020, 34 (01) : 21 - 34
  • [43] Real world single center expeirence of long-term toxicities with anti-BCMA CAR T-cell therapy in relapsed and refractory multiple myeloma
    Costello, Patrick
    Laubach, Jacob
    Mo, Clifton
    Sperling, Adam
    Nikiforow, Sarah
    Redd, Robert
    Ramsdell, Linda
    Finn, Kathleen
    Desnoyers, Lauren
    Denisco, Michelle
    Fraser, Esther
    Bianchi, Giada
    Hartley-Brown, Monique
    Ghobrial, Irene
    Richardson, Paul
    Anderson, Kenneth
    Munshi, Nikhil
    Nadeem, Omar
    Midha, Shonali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S54 - S54
  • [44] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    Mattia D’Agostino
    Noopur Raje
    Leukemia, 2020, 34 : 21 - 34
  • [45] FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS
    Lin, Y.
    Berdeja, J.
    Raje, N.
    Munshi, N.
    Siegel, D.
    Liedtke, M.
    Jagannath, S.
    Maus, M.
    Turka, A.
    Lam, L. P.
    Hege, K.
    Morgan, R.
    Quigley, M. T.
    Kochenderfer, J.
    HAEMATOLOGICA, 2017, 102 : 21 - 21
  • [46] Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma
    Jie, Jin
    Hao, Siguo
    Jiang, Songfu
    Li, Zonghai
    Yang, Min
    Zhang, Wenhao
    Yu, Kang
    Xiao, Jun
    Meng, Haitao
    Ma, Liyuan
    He, Mingxia
    Wang, Wei
    Huang, Xin
    Chen, Linjun
    Xing, Chongyun
    Yuan, Daijing
    Wang, Shasha
    Tao, Rong
    Dai, Lihui
    Ma, Hong
    BLOOD, 2019, 134
  • [47] Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Fandrei, David
    Seiffert, Sabine
    Rade, Michael
    Rieprecht, Susanne
    Gagelmann, Nico
    Born, Patrick
    Wiemers, Thomas
    Weidner, Heike
    Kreuz, Markus
    Schassberger, Tamara
    Kossmann, Jannik
    Mangold, Marlene
    Fuerst, Daniel
    Fischer, Luise
    Baber, Ronny
    Heyn, Simone
    Wang, Song Yau
    Bach, Enrica
    Hoffmann, Sandra
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Koehl, Ulrike
    Friedrich, Maik
    Boldt, Andreas
    Reiche, Kristin
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 38 - 54
  • [48] Association Between Risk Factors and Outcomes Following Fully Human Anti-BCMA CAR-T Progression in Patients with Relapsed/Refractory Multiple Myeloma
    An, Ning
    Wang, Di
    Yu, Qiuxia
    Mu, Wei
    Bao, Yuhan
    Xinran, Wang
    Long, Xiaolu
    Li, Chunrui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S42 - S42
  • [49] Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
    Zhang, Mingming
    Zhou, Linghui
    Zhao, Houli
    Zhang, Yanlei
    Wei, Guoqing
    Hong, Ruimin
    Wu, Wenjun
    Xu, Huijun
    Wang, Linqin
    Ni, Fang
    Cui, Jiazhen
    Peng, Shuixiu
    Huang, Chih-Hua
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6384 - 6392
  • [50] Anti-BCMA CAR T-Cell Therapy in Patients with Refractory Myasthenia Gravis
    Qin, Chuan
    Tian, Dai-Shi
    Dong, Ming-Hao
    Hing, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bi-Tao
    zu Hoerste, Gerd Meyer
    Wang, Wei
    ANNALS OF NEUROLOGY, 2024, 96 : S98 - S99
12345